Literature DB >> 16284482

A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction.

Yongxin Yu1, Timothy J Lyons.   

Abstract

This paper addresses the consequences of diabetes and obesity, diseases that have become epidemic in our society, particularly in the past 20 years. Specifically, it summarizes current knowledge about some of the risk factors and mechanisms for the vascular complications of diabetes. These complications can be broadly divided into microvascular disease, such as diabetic retinopathy and diabetic nephropathy, and macrovascular disease, such as accelerated atherosclerosis, and they are the main cause for morbidity and premature mortality among diabetic patients. The roles of hyperglycemia, dyslipidemia and dyslipoproteinemia, oxidative stress, and endothelial dysfunction will be considered. Finally, the "treatment gap" will be addressed. This gap refers to our failure to achieve currently accepted goals to reduce established risk factors for complications in the clinical management of diabetic patients.

Entities:  

Mesh:

Year:  2005        PMID: 16284482     DOI: 10.1097/00000441-200511000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  28 in total

1.  Cinnamon as a supplemental treatment for impaired glucose tolerance and type 2 diabetes.

Authors:  Amy D Otto
Journal:  Curr Diab Rep       Date:  2010-06       Impact factor: 4.810

2.  Serum uric acid is associated with arterial stiffness in men with newly diagnosed type 2 diabetes mellitus.

Authors:  J Zhang; G Xiang; L Xiang; H Sun
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

3.  Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.

Authors:  Tong Wang; Si-Si Chen; Rui Chen; De-Min Yu; Pei Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 4.  The role of inflammation in diabetic eye disease.

Authors:  Marina Mesquida; Faye Drawnel; Sascha Fauser
Journal:  Semin Immunopathol       Date:  2019-06-07       Impact factor: 9.623

5.  Formation of methionine sulfoxide during glycoxidation and lipoxidation of ribonuclease A.

Authors:  Jonathan W C Brock; Jennifer M Ames; Suzanne R Thorpe; John W Baynes
Journal:  Arch Biochem Biophys       Date:  2006-11-02       Impact factor: 4.013

6.  Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition.

Authors:  Weihua Liu; Futian Tang; Yanhui Deng; Xuejuan Li; Tian Lan; Xiaoyan Zhang; Heqing Huang; Peiqing Liu
Journal:  Mol Cell Biochem       Date:  2009-01-14       Impact factor: 3.396

7.  Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats.

Authors:  Hanke Mollnau; Matthias Oelze; Elena Zinßius; Michael Hausding; Zhixiong Wu; Maike Knorr; Jasmin Ghaemi Kerahrodi; Swenja Kröller-Schön; Thomas Jansen; Christine Teutsch; Carolyn Foster; Huige Li; Philip Wenzel; Eberhard Schulz; Thomas Münzel; Andreas Daiber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-02-27       Impact factor: 3.000

8.  Reduced beta 2 glycoprotein I improve diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.

Authors:  Tong Wang; Si-Si Chen; Rui Chen; De-Min Yu; Pei Yu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  Acute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males.

Authors:  Stacy R Oliver; Rebecca L Flores; Andria M Pontello; Jaime S Rosa; Frank P Zaldivar; Pietro R Galassetti
Journal:  J Investig Med       Date:  2008-10       Impact factor: 2.895

10.  The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta.

Authors:  Yael Riahi; Yoav Sin-Malia; Guy Cohen; Evgenia Alpert; Arie Gruzman; Juergen Eckel; Bart Staels; Michel Guichardant; Shlomo Sasson
Journal:  Diabetes       Date:  2010-01-27       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.